Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
CONCLUSION: Aspirin use may have chemo-preventive effect on recurrence of hepatitis B virus-related HCC after curative resection.
PMID: 31104872 [PubMed - as supplied by publisher]
Source: J Formos Med Assoc - Category: General Medicine Authors: Young SH, Chau GY, Lee IC, Yeh YC, Chao Y, Huo TI, Su CW, Lin HC, Hou MC, Lee MH, Huang YH Tags: J Formos Med Assoc Source Type: research
More News: Aspirin | Cancer | Cancer & Oncology | Carcinoma | Cholesterol | Cirrhosis | General Medicine | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Science | Statin Therapy | Study | Urology & Nephrology